AdvisorShares MSOS Climbs 8% As Cannabis Rescheduling Sparks Investor Interest
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 23 2024
0mins
Source: Benzinga
AdvisorShares' Perspective on Cannabis Industry Growth: AdvisorShares, managing over $1 billion in cannabis-focused ETFs, anticipates significant growth in the U.S. cannabis market due to increasing mainstream acceptance and potential regulatory changes, including the rescheduling of cannabis which could alleviate tax burdens for operators.
Market Impact and ETF Performance: Following positive news regarding cannabis regulations, the MSOS ETF experienced an 8.17% increase, closing at $7.68, indicating strong upward momentum despite potential short-term volatility as indicated by various market indicators.
Analyst Views on MSOS
Wall Street analysts forecast MSOS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MSOS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 4.520
Low
Averages
High
Current: 4.520
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
